Cellular Procoagulant Activity Dictates Clot Structure and Stability as a Function of Distance From the Cell Surface

Background—Thrombin concentration modulates fibrin structure and fibrin structure modulates clot stability; however, the impact of localized, cell surface-driven in situ thrombin generation on fibrin structure and stability has not previously been evaluated. Methods and Results—Human fibroblasts were incubated with factors Xa, Va, prothrombin and fibrinogen, or plasma. Fibrin formation, structure, and lysis were examined using laser scanning confocal microscopy and transmission electron microscopy. In situ thrombin generation on the cell surface produced clots with a significantly denser fiber network in a 10-&mgr;m region proximal versus distal to (40 to 50 &mgr;m) the cell surface. This morphology was not altered by addition of integrin-blocking RGDS peptide and was not apparent in clots made by exogenous thrombin addition, suggesting that spatial morphology was dictated predominantly by localized thrombin generation on the fibroblast surface. The fibrin network lysed more rapidly distal versus proximal to the cell surface, suggesting that the structural heterogeneity of the clot affected its fibrinolytic stability. Conclusions—In situ thrombin generation on the cell surface modulates the three-dimensional structure and stability of the clot. Thrombus formation in vivo may reflect the ability of the local cell population to support thrombin generation and, therefore, the three-dimensional structure and stability of the fibrin network.

[1]  H C Hemker,et al.  The role of phospholipids and factor Va in the prothrombinase complex. , 1980, The Journal of biological chemistry.

[2]  R. Hantgan,et al.  Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis , 2004, Microscopy and Microanalysis.

[3]  R. Clark,et al.  Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. , 1997, Experimental cell research.

[4]  J. Soria,et al.  Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Dhall,et al.  Interaction of endothelial cells and fibroblasts with modified fibrin networks: role in atherosclerosis. , 1997, Atherosclerosis.

[6]  W. Aird Vascular bed‐specific thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.

[7]  P. Carmeliet,et al.  Physiological consequences of loss of plasminogen activator gene function in mice , 1994, Nature.

[8]  K. Carlsson,et al.  Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. , 1994, Thrombosis research.

[9]  J. Weisel,et al.  A Structural and Dynamic Investigation of the Facilitating Effect of Glycoprotein IIb/IIIa Inhibitors in Dissolving Platelet-Rich Clots , 2002, Circulation research.

[10]  J. Soria,et al.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A Liljeborg,et al.  Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. , 1989, Biochimica et biophysica acta.

[12]  Robert A. Campbell,et al.  A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation , 2007, British journal of haematology.

[13]  J. Weisel,et al.  Dynamic imaging of fibrin network formation correlated with other measures of polymerization. , 2007, Blood.

[14]  M. Carr,et al.  Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[15]  F. Ataullakhanov,et al.  Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate * , 2005, Journal of thrombosis and haemostasis : JTH.

[16]  A. Wolberg,et al.  Analyzing fibrin clot structure using a microplate reader , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  L. Languino,et al.  Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway , 1993, Cell.

[18]  Y. Nemerson,et al.  Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. , 2004, Blood.

[19]  Tami L. Bach,et al.  Endothelial Cell VE-cadherin Functions as a Receptor for the β15–42 Sequence of Fibrin* , 1998, The Journal of Biological Chemistry.

[20]  H. Weiler,et al.  Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue‐specific fibrin deposition , 2007, Journal of thrombosis and haemostasis : JTH.

[21]  C. Esmon Molecular Events that Control the Protein C Anticoagulant Pathway , 1993, Thrombosis and Haemostasis.

[22]  H. Bounameaux Factor V Leiden paradox: risk of deepvein thrombosis but not of pulmonary embolism , 2000, The Lancet.

[23]  Alisa S Wolberg,et al.  A Variant of Recombinant Factor VIIa With Enhanced Procoagulant and Antifibrinolytic Activities in an In Vitro Model of Hemophilia , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  James,et al.  The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. , 1988, Blood.

[25]  J. Weisel,et al.  Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. , 1992, Biophysical journal.

[26]  M. Blombäck,et al.  Proneness to Formation of Tight and Rigid Fibrin Gel Structures in Men with Myocardial Infarction at a Young Age , 1996, Thrombosis and Haemostasis.

[27]  M. Blombäck,et al.  Fibrin Gel Network Characteristics and Coronary Heart Disease: Relations to Plasma Fibrinogen Concentration, Acute Phase Protein, Serum Lipoproteins and Coronary Atherosclerosis , 1992, Thrombosis and Haemostasis.

[28]  Alisa S Wolberg,et al.  High dose factor VIIa improves clot structure and stability in a model of haemophilia B , 2005, British journal of haematology.

[29]  J. Weisel,et al.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. , 2005, Blood.

[30]  R. Clark,et al.  Human Fibroblasts Bind Directly to Fibrinogen at RGD Sites through Integrin αvβ3 , 1997 .

[31]  A. Lumsden,et al.  Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. , 2005, Thrombosis research.

[32]  J. Hermans,et al.  Size and density of fibrin fibers from turbidity. , 1978, Macromolecules.

[33]  J. Weisel,et al.  Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Wolberg,et al.  Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. , 2003, Blood.

[35]  H. Rayburn,et al.  A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. , 1998, The Journal of clinical investigation.

[36]  J. Weisel,et al.  Dynamic Changes of Fibrin Architecture during Fibrin Formation and Intrinsic Fibrinolysis of Fibrin-rich Clots* , 2003, Journal of Biological Chemistry.

[37]  Aaron L Fogelson,et al.  Fibrin gel formation in a shear flow. , 2007, Mathematical medicine and biology : a journal of the IMA.

[38]  E Ruoslahti,et al.  The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[40]  D. Farrell,et al.  Human fibroblast adhesion to fibrinogen. , 1997, Biochemistry.